| __timestamp | Alnylam Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 125519000 |
| Thursday, January 1, 2015 | 41097000 | 135522000 |
| Friday, January 1, 2016 | 47159000 | 137780000 |
| Sunday, January 1, 2017 | 76545000 | 162135000 |
| Monday, January 1, 2018 | 73106000 | 174885000 |
| Tuesday, January 1, 2019 | 194688000 | 174811000 |
| Wednesday, January 1, 2020 | 414801000 | 138761000 |
| Friday, January 1, 2021 | 704143000 | 187695000 |
| Saturday, January 1, 2022 | 868601000 | 581703000 |
| Sunday, January 1, 2023 | 1517886000 | 709543000 |
| Monday, January 1, 2024 | 1924873000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, Alnylam Pharmaceuticals and Lantheus Holdings have emerged as key players. Over the past decade, Alnylam has seen a staggering growth in gross profit, skyrocketing from a modest $50 million in 2014 to an impressive $1.5 billion by 2023. This represents a remarkable 2,900% increase, underscoring their innovative prowess in RNA interference therapeutics.
Conversely, Lantheus Holdings, known for its diagnostic imaging solutions, has also experienced significant growth, albeit at a steadier pace. Their gross profit increased from $126 million in 2014 to $709 million in 2023, marking a 460% rise. This steady climb highlights their consistent market presence and strategic expansions.
As these companies continue to innovate, their financial trajectories offer a fascinating glimpse into the future of biotechnology and healthcare solutions.
Gross Profit Analysis: Comparing Merck & Co., Inc. and Lantheus Holdings, Inc.
Gross Profit Trends Compared: AstraZeneca PLC vs Lantheus Holdings, Inc.
Key Insights on Gross Profit: Zoetis Inc. vs Lantheus Holdings, Inc.
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Alkermes plc
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Veracyte, Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Lantheus Holdings, Inc. or Travere Therapeutics, Inc.